Serving Customers All Over the USA and Europe
Our Mission
Established in 2018, our goal is to transform human and pet oral care. The word Pontis is derived from “pontem”, which is Latin for “bridge.” By bridging our mechanistic insights with therapeutic design and industry insights, we are poised to redefine and elevate the standards of health.
Our Team
PONTIS has assembled a team with complementary skillsets to ensure expertise across science and business.
Miguel Titarelli
CEO, a decade of experience in the healthcare space. Miguel was a consultant and project lead at multiple pharmaceutical and MedTech focused management consulting firms and most recently drove commercial strategy and execution at Mahana Therapeutics
Dr. Dennis Mynarcik
CSO and Founder, PhD In Biochemistry/ enzymology from Cornell, post doc work at Sloan-Kettering, later joined Stony Brook University. Over 20 years experience in biotechnology, founder/co-founder of biotech companies: Evotope Biosciences and Pontis.
Barbara Mish
Head of Analytics, Manager Barry Bloom’s HHMI AECOM, CSHL microarray neuro facility, Pall Corp. Hematologic Lab